Study guide
12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria
Certified Burn Registered Nurse CBRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Foundations of Burn Care
1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones
2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response
2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology
3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria
3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics
4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)
4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy
5 Chapter 5: Airway Management & Inhalation Injury Management
5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
6 Chapter 6: Acute Multisystem Assessment & Critical Care Management
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
7 Chapter 7: Hypermetabolism & Nutritional Support
7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation
8 Chapter 8: Pain Management in Burn Care
8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction
9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus
9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients
10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings
10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances
11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure
11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management
12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy
12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion
13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries
13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy
14 Chapter 14: Special Burn Populations & Cutaneous Syndromes
14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries
15 Chapter 15: Rehabilitation, Scar Management & Reconstruction
15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management
16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage
16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response
12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria
Key Takeaways Explain This Topic AI
Standard ACCP/SCCM Systemic Inflammatory Response Syndrome (SIRS) and Sepsis-3 definitions are non-specific and clinically useless in major burns (>20% TBSA) because massive hypermetabolism causes persistent baseline tachycardia, tachypnea, fever, and leukocytosis in the absence of infection.
The American Burn Association (ABA) Consensus Sepsis Criteria establish that burn sepsis requires meeting at least THREE of six specific clinical/laboratory trigger parameters in the presence of a documented or suspected infectious source.
The six ABA sepsis triggers include: Core temperature >39.0°C or <36.5°C; Sustained tachycardia >110 bpm; Progressive tachypnea (>25 bpm or minute ventilation >12 L/min); Thrombocytopenia (<100,000/mcL or >50% acute decline); Unexplained hyperglycemia (>140 mg/dL or >20–30% increase in insulin requirements); and Enteral feeding intolerance.
New-onset enteral feeding intolerance—defined as gastric residual volumes >200 mL, abdominal distension, diarrhea, or ileus lasting >24 hours—is a highly sensitive early indicator of splanchnic vasoconstriction, hypoperfusion, and occult burn sepsis.
Serial kinetic monitoring of procalcitonin (PCT) and worsening metabolic acidosis (rising arterial lactate >2.0 mmol/L and expanding base deficit) provide critical objective validation of invasive sepsis, substantially outperforming static C-reactive protein (CRP) or white blood cell counts.
Last updated: August 2026
12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria
Core Knowledge: Severe thermal injury triggers a sustained, hyperadrenergic hypermetabolic response that mimics systemic inflammatory response syndrome (SIRS). In patients with > 20 % >20\% > 20% Total Body Surface Area (TBSA) burns, resting tachycardia ( > 100 – 110 bpm >100\text{--}110\text{ bpm} > 100 – 110 bpm ), baseline hyperventilation, hyperthermia ( 38.0 ∘ C– 38.5 ∘ C 38.0^\circ\text{C--}38.5^\circ\text{C} 38. 0 ∘ C– 38. 5 ∘ C ), and leukocytosis are normal physiological baseline findings. Consequently, traditional SIRS and Sepsis-3 criteria lack specificity in burn care. The American Burn Association (ABA) Consensus Sepsis Criteria provide burn-specific physiological and metabolic thresholds required to accurately detect sepsis.
1. The Diagnostic Dilemma: Hypermetabolic Baseline vs. True Sepsis
In standard medical-surgical intensive care units, sepsis screening relies on the presence of SIRS (temperature > 38.0 ∘ C >38.0^\circ\text{C} > 38. 0 ∘ C or < 36.0 ∘ C <36.0^\circ\text{C} < 36. 0 ∘ C , heart rate > 90 bpm >90\text{ bpm} > 90 bpm , respiratory rate > 20 breaths/min >20\text{ breaths/min} > 20 breaths/min , and WBC > 12 , 000 / μ L \text{WBC} >12,000/\mu\text{L} WBC > 12 , 000/ μ L ) or Sequential Organ Failure Assessment (SOFA) score shifts. However, in major burn trauma, the massive release of catecholamines, cortisol, glucagon, and inflammatory cytokines (IL-1, IL-6, TNF- α \alpha α ) elevates the baseline metabolic rate by up to 100 % to 200 % 100\%\text{ to }200\% 100% to 200% . THE BURN SEPSIS DIAGNOSTIC DILEMMA
- ┌────────────────────────────────────────┬────────────────────────────────────────┐
- │ BASELINE BURN HYPERMETABOLISM │ TRUE INVASIVE BURN SEPSIS │
- ├────────────────────────────────────────┼────────────────────────────────────────┤
- │ • HR 100–110 bpm (Hyperadrenergic) │ • HR >110 bpm (or >2 SD above norm) │
- │ • RR 20–24 bpm (Hypermetabolic drive) │ • RR >25 bpm or Minute Vent >12 L/min │
- │ • Core Temp 38.0°C–38.5°C (Reset point)│ • Core Temp >39.0°C or Hypothermia<36.5│
- │ • WBC 12,000–18,000/mcL (Demargination)│ • Thrombocytopenia (<100k or >50% drop)│
- │ • Stable glycemic control on regimen │ • Insulin resistance (>20–30% increase)│
- │ • Tolerating goal enteral nutrition │ • Enteral feeding intolerance (GRV>200)│
- └────────────────────────────────────────┴────────────────────────────────────────┘
Applying standard SIRS criteria to a burn patient results in near-100% false-positive rates, leading to inappropriate antibiotic overuse, induction of multidrug resistance, and diagnostic fatigue. Clinicians must look beyond baseline hypermetabolism to identify specific, acute physiological deviations.
2. American Burn Association (ABA) Consensus Sepsis Criteria
To overcome these diagnostic barriers, the American Burn Association established standardized consensus criteria. A diagnosis of Burn Sepsis requires the presence of a documented or strongly suspected source of infection AND at least THREE (3) of the following six clinical and laboratory criteria: ABA CONSENSUS SEPSIS CRITERIA MATRIX
- ┌────────────────────────────────────────────────────────────────────────┐
- │ REQUIREMENT: Documented/Suspected Infection + AT LEAST 3 CRITERIA: │
- ├─────┬──────────────────────────┬───────────────────────────────────────┤
- │ 1 │ Core Temperature │ > 39.0°C (102.2°F) OR < 36.5°C (97.7°F)│
- ├─────┼──────────────────────────┼───────────────────────────────────────┤
- │ 2 │ Progressive Tachycardia │ > 110 beats/min (Adults) or >2 SD age │
- ├─────┼──────────────────────────┼───────────────────────────────────────┤
- │ 3 │ Progressive Tachypnea │ > 25 breaths/min (unventilated) OR │
- │ │ │ Minute Ventilation > 12 L/min (vent) │
- ├─────┼──────────────────────────┼───────────────────────────────────────┤
- │ 4 │ Thrombocytopenia │ Platelets < 100,000/mcL (or >50% drop │
- │ │ │ within 3 days after initial resusc) │
- ├─────┼──────────────────────────┼───────────────────────────────────────┤
- │ 5 │ Hyperglycemia / Insulin │ Unexplained Glucose > 140 mg/dL OR │
- │ │ Resistance │ > 20%–30% increase in insulin demand │
- ├─────┼──────────────────────────┼───────────────────────────────────────┤
- │ 6 │ Enteral Feeding │ Gastric Residual Volume > 200 mL, │
- │ │ Intolerance │ Abdominal distension, or Ileus > 24h │
- └─────┴──────────────────────────┴───────────────────────────────────────┘
In-Depth Analysis of the Six ABA Criteria:
1. Severe Dysthermia (Core Temp > 39.0 ∘ C >39.0^\circ\text{C} > 39. 0 ∘ C or < 36.5 ∘ C <36.5^\circ\text{C} < 36. 5 ∘ C )
While baseline central thermoregulation is reset upward to 38.0 ∘ C– 38.5 ∘ C 38.0^\circ\text{C--}38.5^\circ\text{C} 38. 0 ∘ C– 38. 5 ∘ C in burns, a spike above 39.0°C (102.2°F) signals pyrogen release from active microbial invasion. Conversely, hypothermia (<36.5°C / 97.7°F) is an ominous indicator of overwhelming Gram-negative endotoxemia, impaired thermogenesis, and imminent septic shock.
2. Sustained Tachycardia ( > 110 bpm >110\text{ bpm} > 110 bpm )
Resting heart rates of 90 – 105 bpm 90\text{--}105\text{ bpm} 90 – 105 bpm reflect baseline catecholaminergic drive. A progressive increase exceeding 110 bpm in adults (or > 2 >2 > 2 standard deviations above age-adjusted normal in pediatric patients) that does not respond to fluid boluses or analgesia reflects systemic vasodilatory compensation or myocardial depression from circulating sepsis mediators.
3. Progressive Tachypnea / Elevated Minute Ventilation
In spontaneously breathing patients, a respiratory rate > 25 breaths/min >25\text{ breaths/min} > 25 breaths/min indicates an escalating drive to compensate for metabolic acidosis or secondary acute lung injury. In mechanically ventilated patients, a minute ventilation exceeding 12 L/min (or > 200 % of predicted >200\%\text{ of predicted} > 200% of predicted ) indicates hypermetabolic acceleration and expanding physiological dead space.
4. Thrombocytopenia (Platelets < 100 , 000 / μ L <100,000/\mu\text{L} < 100 , 000/ μ L or > 50 % >50\% > 50% Drop)
Following initial post-resuscitation nadir (Days 2–3), platelet counts typically rebound to supranormal levels ( 400 , 000 – 800 , 000 / μ L 400,000\text{--}800,000/\mu\text{L} 400 , 000 – 800 , 000/ μ L ) as an acute-phase reactant. A sudden, unexplained drop below 100,000/mcL —or a rapid > 50 % >50\% > 50% decline from the patient's post-resuscitation peak—indicates platelet consumption in microvascular microthrombi (disseminated intravascular coagulation [DIC]) and direct bacterial endotoxin-mediated destruction.
5. Unexplained Hyperglycemia & Insulin Resistance
A sudden elevation of blood glucose > 140 mg/dL >140\text{ mg/dL} > 140 mg/dL ( > 7.8 mmol/L >7.8\text{ mmol/L} > 7.8 mmol/L ) in a non-diabetic patient, or a > 20 % to 30 % >20\%\text{ to }30\% > 20% to 30% surge in baseline intravenous insulin infusion rate required to maintain euglycemia over a 24-hour period, is a classic harbinger of sepsis. Microbial cytokines trigger severe peripheral insulin receptor desensitization and accelerated hepatic gluconeogenesis.
6. Enteral Feeding Intolerance
During sepsis, endothelin release and sympathetic hyperactivity induce selective mesenteric vasoconstriction, causing gut mucosal ischemia and gastroparesis. Feeding intolerance is clinically defined as:
- Gastric residual volumes (GRV) > 200 mL >200\text{ mL} > 200 mL (or twice the hourly infusion rate);
- Severe abdominal distension or new diarrhea;
Inability to tolerate enteral feeds resulting in feed discontinuation for > 24 hours >24\text{ hours} > 24 hours .
3. Laboratory Biomarkers and Perfusion Indicators
While the ABA Consensus Criteria establish clinical triggers, laboratory biomarkers provide essential corroboration to differentiate non-infectious inflammation from bacterial/fungal invasion. BIOMARKER PROFILE IN BURN SEPSIS EVALUATION
- ┌────────────────────┬───────────────────────────────────────────────────┐
- │ Biomarker │ Clinical Utility & Diagnostic Behavior in Burns │
- ├────────────────────┼───────────────────────────────────────────────────┤
- │ Procalcitonin │ HIGH SPECIFICITY. Elevated kinetics (>0.5–2.0 │
- │ (PCT Trends) │ ng/mL or >2-fold daily rise) correlate strongly │
- │ │ with systemic bacterial sepsis. Superior to CRP. │
- ├────────────────────┼───────────────────────────────────────────────────┤
- │ Arterial Lactate │ Lactate >2.0 mmol/L indicates cellular dysoxia, │
- │ & Base Deficit │ microvascular occlusion, and anaerobic metabolism;│
- │ │ Base deficit expanding more negative than -4 mEq/L│
- ├────────────────────┼───────────────────────────────────────────────────┤
- │ C-Reactive Protein │ LOW SPECIFICITY. Markedly elevated at baseline by │
- │ (CRP) │ burn trauma; useful ONLY for longitudinal trends │
- │ │ to evaluate resolution following therapy. │
- ├────────────────────┼───────────────────────────────────────────────────┤
- │ White Blood Cell │ Poor diagnostic value in burns. Leukocytosis is │
- │ Count (WBC) │ baseline; profound LEUKOPENIA (<4,000/mcL) is │
- │ │ an ominous sign of overwhelming Gram-negative shock│
- └────────────────────┴───────────────────────────────────────────────────┘
Procalcitonin (PCT) Kinetics:
Procalcitonin is produced ubiquitously by parenchymal cells in response to bacterial endotoxins and pro-inflammatory cytokines (IL-1 β \beta β , TNF- α \alpha α ), while being inhibited by viral interferon- γ \gamma γ . In burn patients, a single static value is less informative than kinetic serial tracking . A continuous upward trajectory or a sharp spike ( > 2.0 ng/mL >2.0\text{ ng/mL} > 2.0 ng/mL ) strongly discriminates bacterial burn sepsis from non-infectious hypermetabolism.
Serum Lactate and Base Deficit Dynamics:
An acute increase in arterial blood lactate > 2.0 mmol/L >2.0\text{ mmol/L} > 2.0 mmol/L or an expanding negative base deficit ( < − 4 to − 6 mEq/L <-4\text{ to }-6\text{ mEq/L} < − 4 to − 6 mEq/L ) in a resuscitated burn patient indicates microcirculatory perfusion collapse, tissue dysoxia, and progressive mitochondrial dysfunction secondary to sepsis.